TIE2 activation by antibody-clustered endogenous angiopoietin-2 prevents capillary loss and fibrosis in experimental kidney disease.

Both ABTAA treatment and Veptp iECKO elicited a generally reduced response, though most did not reach statistical significance ( Figure 7A and Supplemental Data File 2).

also in 111,027 other papers